{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,30]],"date-time":"2022-03-30T08:15:56Z","timestamp":1648628156001},"reference-count":5,"publisher":"Elsevier BV","issue":"6-7","license":[{"start":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T00:00:00Z","timestamp":1464739200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Revue Neurologique"],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1016\/j.neurol.2016.03.005","type":"journal-article","created":{"date-parts":[[2016,5,2]],"date-time":"2016-05-02T09:37:49Z","timestamp":1462181869000},"page":"398-399","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Parkinson's disease, hyperhomocysteinemia and thrombosis: A dangerous combination"],"prefix":"10.1016","volume":"172","author":[{"given":"S.","family":"Bellakhal","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Gharbi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Z.","family":"Meddeb","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Mrouki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.","family":"Abdelk\u00e9fi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.-H.","family":"Douggui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.neurol.2016.03.005_bib0030","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1034\/j.1600-0404.2003.00135.x","article-title":"Levodopa induced hyperhomocysteinaemia in Parkinson's disease","volume":"108","author":"Yasui","year":"2003","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.neurol.2016.03.005_bib0035","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.jns.2013.09.006","article-title":"Methylene tetrahydrofolate reductase (MTHFR) C677T\/A1298C polymorphisms and susceptibility to Parkinson's disease: a meta-analysis","volume":"335","author":"Wu","year":"2013","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.neurol.2016.03.005_bib0040","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1111\/j.1468-1331.2004.00973.x","article-title":"Hyperhomocysteinemia in L-dopa treated Parkinson's disease patients: effect of cobalamin and folate administration","volume":"12","author":"Lamberti","year":"2005","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.neurol.2016.03.005_bib0045","doi-asserted-by":"crossref","first-page":"33","DOI":"10.14802\/jmd.09008","article-title":"Hyperhomocysteinemia in patients with Parkinson's disease and relationship to vitamin B level","volume":"2","author":"Shin","year":"2009","journal-title":"J Mov Disord"},{"key":"10.1016\/j.neurol.2016.03.005_bib0050","doi-asserted-by":"crossref","first-page":"e66984","DOI":"10.1371\/journal.pone.0066984","article-title":"Postural abnormality as a risk marker for leg deep venous thrombosis in Parkinson's disease","volume":"8","author":"Yamane","year":"2013","journal-title":"PLoS One"}],"container-title":["Revue Neurologique"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S003537871530045X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S003537871530045X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,12]],"date-time":"2018-09-12T10:52:04Z","timestamp":1536749524000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S003537871530045X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6]]},"references-count":5,"journal-issue":{"issue":"6-7","published-print":{"date-parts":[[2016,6]]}},"alternative-id":["S003537871530045X"],"URL":"https:\/\/doi.org\/10.1016\/j.neurol.2016.03.005","relation":{},"ISSN":["0035-3787"],"issn-type":[{"value":"0035-3787","type":"print"}],"subject":[],"published":{"date-parts":[[2016,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Parkinson's disease, hyperhomocysteinemia and thrombosis: A dangerous combination","name":"articletitle","label":"Article Title"},{"value":"Revue Neurologique","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neurol.2016.03.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}